BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34388529)

  • 1. A review on the role of PCAT6 lncRNA in tumorigenesis.
    Ghafouri-Fard S; Khoshbakht T; Taheri M; Ebrahimzadeh K
    Biomed Pharmacother; 2021 Oct; 142():112010. PubMed ID: 34388529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PCAT6 aggravates the progression of bladder cancer cells by targeting miR-513a-5p.
    Xia W; Chen C; Zhang MR; Zhu LN
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9908-9914. PubMed ID: 33090394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of long non-coding RNA PCAT6 restrains gastric cancer cell proliferation and epithelial-mesenchymal transition by targeting microRNA-15a.
    Dong D; Lun Y; Sun B; Sun H; Wang Q; Yuan G; Quan J
    Gen Physiol Biophys; 2020 Jan; 39(1):1-12. PubMed ID: 32039820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis.
    Wang W; Li X; Guan C; Hu Z; Zhao Y; Li W; Jiang X
    Pathol Res Pract; 2020 Sep; 216(9):153074. PubMed ID: 32825947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling.
    Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
    Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p.
    Meng Q; Yang BY; Liu B; Yang JX; Sun Y
    Int J Biol Markers; 2018 May; 33(2):148-155. PubMed ID: 29799357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising role of long non-coding RNA PCAT6 in malignancies.
    Li M; Yu X; Zheng Q; Zhang Q; He Y; Guo W
    Biomed Pharmacother; 2021 May; 137():111402. PubMed ID: 33761616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies.
    Ghafouri-Fard S; Dashti S; Farsi M; Hussen BM; Taheri M
    Biomed Pharmacother; 2021 May; 137():111366. PubMed ID: 33601149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCAT6 mediates cellular biological functions in gastrointestinal stromal tumor via upregulation of PRDX5 and activation of Wnt pathway.
    Bai F; Zhang N; Fang W; He X; Zheng Y; Gu D
    Mol Carcinog; 2020 Jun; 59(6):661-669. PubMed ID: 32339330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p.
    Wu W; Zhao Y; Gao E; Li Y; Guo X; Zhao T; He W; Zhang H
    J Cell Mol Med; 2020 Jan; 24(1):441-450. PubMed ID: 31721438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p.
    Yu HM; Wang C; Yuan Z; Chen GL; Ye T; Yang BW
    Cell Prolif; 2019 Jan; 52(1):e12526. PubMed ID: 30407674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA PCAT6 Regulated by YY1 Accelerates the Progression of Glioblastoma via miR-513/IGF2BP1.
    Liu P; Zhao P; Li B; Xu D; Wang K
    Neurochem Res; 2020 Dec; 45(12):2894-2902. PubMed ID: 32990800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA PCAT6 activated by SP1 facilitates the progression of breast cancer by the miR-326/LRRC8E axis.
    Zhu Q; Wang S; Shi Y
    Anticancer Drugs; 2022 Feb; 33(2):178-190. PubMed ID: 34620745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA PCAT6 regulates bladder cancer progression via the microRNA-143-3p/PDIA6 axis.
    Zhang Y; Chen L; Luo G
    Exp Ther Med; 2021 Sep; 22(3):947. PubMed ID: 34335889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
    Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
    Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α.
    Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX
    Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression.
    Guan X; Xu Y; Zheng J
    Oncol Rep; 2020 Dec; 44(6):2465-2474. PubMed ID: 33125146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
    Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B
    J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
    Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
    Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
    J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.